Table 1 Patient demographics.
From: Clustering of Parkinson subtypes reveals strong influence of DRD2 polymorphism and gender
Number of patients | 91 |
Sex men/women (% men) | 62 (68%) |
Age at onset (years) | 58 (± 10) |
Symptom onset left (% left) | 44 (48%) |
Disease progression ‘off’ | 5 (± 2) |
Medication response | 0.41 (± 0.2) |
Tremor-/akinetic-rigid-score (T-/AR-score) | 0.3 (± 0.5) |
DRD2 Taq1A (rs1800497) Risk type (A/A or A/G) | 27 (30%) |
DRD3 Ser9Gly (rs6208) Risk type (C/C or C/T) | 36 (40%) |
